For success in bioelectronics, build with nature-inspired design
Researchers at WashU have developed bioelectronic scaffolds in a unique way that creates new tissues.
WashU Medicine launches center for rare diseases
WashU Medicine has launched the Center for Rare, Undiagnosed and Genetic Diseases, which brings together researchers and patient communities to create a collaborative network to drive innovative research and accelerate drug discovery.
Garcia to study protein arginylation
Benjamin Garcia, the Raymond H. Wittcoff Distinguished Professor at WashU Medicine, along with colleagues Zongtao (Tom) Lin and Dongwen Lyu, received a four-year $2.4 million grant renewal from the National Heart, Lung and Blood Institute, part of the National Institutes of Health (NIH).
Study highlights barriers to genetic testing for Black children
A recent study by WashU Medicine researchers found Black children were about half as likely as white children to obtain genetic testing ordered by their neurologists.
Rutledge-Jukes named to Forbes’ ’30 under 30′
Heath Rutledge-Jukes, 25, a second-year student at WashU Medicine, has earned a spot on Forbes’ “30 Under 30” education list.
Mwirigi awarded HHMI fellowship for exceptional early-career scientists
Neuroscientist Juliet Mwirigi, a postdoctoral researcher in the Department of Anesthesiology at WashU Medicine, has been named a Hanna H. Gray Fellow by the Howard Hughes Medical Institute.
Olin launches new Business of Health initiative
WashU Olin Business School recently launched a new health initiative that envisions Olin as the premier institution for the business of health and an engine for innovation at WashU.
WashU Medicine and Weizmann Institute of Science establish joint research program
WashU Medicine and the Weizmann Institute of Science have launched a collaboration to support joint research projects focused on understanding the role of microbes and the immune and nervous systems in human health and disease.
Nasal COVID-19 vaccine based on WashU technology to enter U.S. clinical trials
A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S.
NIH awards $10 million to study human virome
Researchers at WashU Medicine have received two grants totaling more than $10 million from the National Institutes of Health (NIH) to study the human body’s resident viruses, those not known to be associated with disease.
Older Stories